<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>Foundation of Henan Educational Committee</funding><funding>NIDDK NIH HHS</funding><funding>National Natural Science Foundation of China-Henan Joint Fund</funding><funding>National Natural Science Foundation of China</funding><pagination>eaaw3172</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9719290</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(540)</volume><pubmed_abstract>Myocardial infarction (MI) is a leading cause of death worldwide for which there is no cure. Although cardiac cell death is a well-recognized pathological mechanism of MI, therapeutic blockade of cell death to treat MI is not straightforward. Death receptor 5 (DR5) and its ligand TRAIL [tumor necrosis factor (TNF)-related apoptosis-inducing ligand] are up-regulated in MI, but their roles in pathological remodeling are unknown. Here, we report that blocking TRAIL with a soluble DR5 immunoglobulin fusion protein diminished MI by preventing cardiac cell death and inflammation in rats, pigs, and monkeys. Mechanistically, TRAIL induced the death of cardiomyocytes and recruited and activated leukocytes, directly and indirectly causing cardiac injury. Transcriptome profiling revealed increased ex</pubmed_abstract><journal>Science translational medicine</journal><pubmed_title>Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and rats.</pubmed_title><pmcid>PMC9719290</pmcid><funding_grant_id>81670271</funding_grant_id><funding_grant_id>U1404801</funding_grant_id><funding_grant_id>T32 DK007780</funding_grant_id><funding_grant_id>14A416008</funding_grant_id><pubmed_authors>Lou Q</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Ren Z</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Lou X</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Ye Y</pubmed_authors><pubmed_authors>Guo R</pubmed_authors><pubmed_authors>Gao E</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Zong B</pubmed_authors><pubmed_authors>Qi Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhao D</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Cheng G</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Chai L</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Shi G</pubmed_authors><pubmed_authors>Chen YH</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Tao N</pubmed_authors><pubmed_authors>Liu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and rats.</name><description>Myocardial infarction (MI) is a leading cause of death worldwide for which there is no cure. Although cardiac cell death is a well-recognized pathological mechanism of MI, therapeutic blockade of cell death to treat MI is not straightforward. Death receptor 5 (DR5) and its ligand TRAIL [tumor necrosis factor (TNF)-related apoptosis-inducing ligand] are up-regulated in MI, but their roles in pathological remodeling are unknown. Here, we report that blocking TRAIL with a soluble DR5 immunoglobulin fusion protein diminished MI by preventing cardiac cell death and inflammation in rats, pigs, and monkeys. Mechanistically, TRAIL induced the death of cardiomyocytes and recruited and activated leukocytes, directly and indirectly causing cardiac injury. Transcriptome profiling revealed increased ex</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2025-04-04T07:47:56.43Z</modification><creation>2025-04-04T07:47:56.43Z</creation></dates><accession>S-EPMC9719290</accession><cross_references><pubmed>32321866</pubmed><doi>10.1126/scitranslmed.aaw3172</doi></cross_references></HashMap>